Boston Partners Trims Holdings in VAREX IMAGING $VREX

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Boston Partners lessened its holdings in shares of VAREX IMAGING (NASDAQ:VREX - Free Report) by 96.8% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,253 shares of the company's stock after selling 578,509 shares during the quarter. Boston Partners' holdings in VAREX IMAGING were worth $223,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Assenagon Asset Management S.A. increased its position in VAREX IMAGING by 6.5% during the 1st quarter. Assenagon Asset Management S.A. now owns 113,573 shares of the company's stock worth $1,317,000 after purchasing an additional 6,953 shares in the last quarter. SG Americas Securities LLC acquired a new stake in VAREX IMAGING during the 1st quarter worth approximately $1,092,000. GAMMA Investing LLC increased its position in VAREX IMAGING by 960.3% during the 1st quarter. GAMMA Investing LLC now owns 16,170 shares of the company's stock worth $188,000 after purchasing an additional 14,645 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in VAREX IMAGING during the 4th quarter worth approximately $190,000. Finally, Deutsche Bank AG increased its position in VAREX IMAGING by 84.5% during the 4th quarter. Deutsche Bank AG now owns 31,463 shares of the company's stock worth $459,000 after purchasing an additional 14,407 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Wall Street Zen downgraded shares of VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. B. Riley reissued a "buy" rating and set a $16.00 target price (up previously from $12.00) on shares of VAREX IMAGING in a research report on Friday, August 8th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $19.50.

VAREX IMAGING Stock Up 2.5%

NASDAQ VREX traded up $0.28 on Friday, reaching $11.62. The company had a trading volume of 399,272 shares, compared to its average volume of 561,517. The firm has a market capitalization of $482.23 million, a PE ratio of -3.62 and a beta of 0.68. VAREX IMAGING has a 1 year low of $6.76 and a 1 year high of $16.93. The firm has a 50-day moving average of $8.55 and a 200-day moving average of $9.48. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.51 and a quick ratio of 1.82.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.14. The firm had revenue of $203.00 million during the quarter, compared to analysts' expectations of $190.32 million. VAREX IMAGING had a positive return on equity of 5.54% and a negative net margin of 16.13%. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. On average, equities research analysts anticipate that VAREX IMAGING will post 0.53 EPS for the current fiscal year.

VAREX IMAGING Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.